Dyadic International, Inc.
NASDAQ:DYAIBiotechnology
+$0.26 today
- Market cap
- $53.56M
- Beta
- 1.15
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$0.20
Volume 0.71M
Average 0.31M
DYAI EBITDA Margin
EBITDA as a percentage of revenue.
Dyadic International, Inc.NASDAQ: DYAI
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to -166.1%
EBITDA Margin was -166.1% in Q1 FY2026, up 872.8 pp from a year earlier. On a trailing-twelve-month basis it was -230.3%, down 71.7 pp year over year. Over 3 fiscal years it narrowed by 215.4 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 2 analysts of -100.0% for the fiscal year ending Dec 2026, up from -560.6% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -166.1%+442.5 pp QoQ
- Last fiscal yearDec 2025
- -560.6%-406.7 pp YoY
- LTMMar 2026
- -230.3%-71.7 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -560.6%
- Year-over-year change
- -406.7pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -560.6% | -406.7pp |
| FY2024 | 2024-12-31 | -154.0% | +127.3pp |
| FY2023 | 2023-12-31 | -281.3% | +64.0pp |
| FY2022 | 2022-12-31 | -345.2% | +118.2pp |
| FY2021 | 2021-12-31 | -463.4% | — |
EBITDA Margin vs competitors
How DYAI compares with its peers on the latest reported figures
- DYAI's LTM Mar 2026 EBITDA Margin of -230.3% is the highest of the 4 companies compared; the peer median is -292.4%.
- Its year-over-year change of -71.7 pp is the 3rd highest of 4, against a peer median of +217.9 pp.
- Over three fiscal years its change of -215.4 pp compares with a peer median of +275.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -230.3% | -71.7 pp | -215.4 pp | |
| FY2025 | -269.0% | +217.9 pp | +70.4 pp | |
| LTM Dec 2025 | -292.4% | -215.5 pp | +479.8 pp | |
| LTM Mar 2026 | -823.9% | +2311.5 pp | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding DYAI) | -292.4% | +217.9 pp | +275.1 pp | |
Competitors are the stored peer set for DYAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.4M | 2.93M | 2.9M | 3.5M | 1.23M |
| Cost of Revenue | 1.94M | 2.12M | 1.98M | 1.19M | 2.32M |
| Gross Profit | 459.39K | 807.11K | 922.96K | 2.3M | (1.09M) |
| Gross Margin | 19.1% | 27.5% | 31.8% | 65.8% | -88.3% |
| Research & Development | 8.39M | 4.5M | 3.3M | 2.04M | 2.15M |
| Selling, General & Admin | 6.7M | 6.42M | 5.82M | 6.13M | 5.76M |
| Operating Expenses | 15.19M | 10.97M | 9.15M | 8.2M | 6.06M |
| Depreciation & Amortization | 3.49M | 0 | 38.42K | 0 | 0 |
| EBITDA | (11.14M) | (10.12M) | (8.15M) | (5.38M) | (6.91M) |
| EBITDA Margin | -463.4% | -345.2% | -281.3% | -154.0% | -560.6% |
| Operating Income | (14.73M) | (10.17M) | (8.23M) | (5.9M) | (7.15M) |
| Operating Margin | -612.7% | -346.9% | -283.9% | -168.8% | -579.9% |
| Interest Income | 51.7K | 180.42K | 416.69K | 456.99K | 284.09K |
| Interest Expense | 0 | 0 | 0 | 427.97K | 455.9K |
| Other Income / Expenses | 1.66M | 430.42K | 1.43M | 91.66K | (218.71K) |
| Income Before Tax | (13.07M) | (9.74M) | (6.8M) | (5.81M) | (7.36M) |
| Pre-Tax Margin | -543.7% | -332.2% | -234.4% | -166.2% | -597.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (13.07M) | (9.74M) | (6.8M) | (5.81M) | (7.36M) |
| Net Margin | -543.7% | -332.2% | -234.4% | -166.2% | -597.6% |
| EPS (Basic) | (0.47) | (0.34) | (0.24) | (0.20) | (0.23) |
| EPS (Diluted) | (0.47) | (0.34) | (0.24) | (0.20) | (0.23) |
| Weighted Avg Shares | 27.84M | 28.36M | 28.8M | 29.32M | 32.62M |
| Weighted Avg Shares (Diluted) | 27.84M | 28.36M | 28.8M | 29.32M | 32.62M |
Dyadic International, Inc.
NASDAQ:DYAI
Intrinsic Alpha fair value
Locked
Current Price
$1.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.